Sort
51,593 grants matching “hepatitis”
Psychoeducation for HCV and Alcohol Behaviors
$587,486Carol S North · Ut Southwestern Medical Center · R01 · FY2007 · AA
Hepatic Gene Transfer for Treatment of Hemophilias A & B
$587,482Mark A Kay · Stanford University · R01 · FY2010 · HL
Liver Preservation for Transplantation
$587,482John J Lemasters · Medical University Of South Carolina · R01 · FY2009 · DK
Adenovirus hexon and its role in virus interaction with the host
$587,464Dmitry Shayakhmetov · Emory University · R01 · FY2015 · AI
Iron Deficiency and Anemia in HIV and HCV-Infected Women
$587,460Johns Hopkins University · R01 · FY2003 · DA
Metabolic Reprogramming by Protease-activated Receptor 2
$587,400Athan Kuliopulos · Tufts Medical Center · R01 · FY2022 · DK
MicroRNAs in Alcoholic Liver Disease
$587,355Gyongyi Szabo · Beth Israel Deaconess Medical Center · R01 · FY2019 · AA
microRNAs in Human Cancer
$587,321Gregory J Hannon · Cold Spring Harbor Laboratory · P01 · FY2007 · CA
Regulation and Role of Phosphatidate Phosphatase in Lipid Metabolism
$587,290George M. Carman · Rutgers, The State Univ Of N.J. · R35 · FY2020 · GM
MR-Image Guided Focused Ultrasound for Treatment of Liver and Renal Cancer
$587,240Kim Butts Pauly · Stanford University · R01 · FY2007 · CA
Intestinal Resection Associated Liver Injury and Fibrosis
$587,221Brad Wayne Warner · Washington University · R01 · FY2021 · DK
Single cell opioid (fentanyl) responses in the context of HIV
$587,188Jason T Blackard · University Of Cincinnati · R01 · FY2025 · DA
Treatment Study Using Depot Naltrexone(1/6)Philadelphia Coord/Data Mgmt Site
$587,187Charles P O'Brien · University Of Pennsylvania · R01 · FY2011 · DA
Liver Disease and HIV-HBV Coinfection in the HAART era
$587,069Chloe L Thio · Johns Hopkins University · R01 · FY2008 · AI
Altered Hepatic Disposition of Anionic Drugs-Mechanisms
$587,047Kim L Brouwer · Univ Of North Carolina Chapel Hill · R01 · FY2015 · GM
Community-based Self-management of HIV and Chronic Disease
$587,018Sheryl L Catz · Kaiser Foundation Health Plan Of Washington · R01 · FY2007 · MH
Drug eluting injectable biomaterials for next generation chemoembolization
$587,009Rahmi Oklu · Mayo Clinic Arizona · R01 · FY2024 · CA
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
$586,990Neil J. Freedman · Duke University · R01 · FY2023 · HL
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
$586,990Neil J. Freedman · Duke University · R01 · FY2025 · HL
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis
$586,990Neil J. Freedman · Duke University · R01 · FY2022 · HL
Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration
$586,862Joannes B Hoek · Thomas Jefferson University · R01 · FY2019 · AA
Community-based interventions to reduce mortality from neonatal infection
$586,847Waldemar A. Carlo · University Of Alabama At Birmingham · U01 · FY2008 · HD
A Human-Centered Pharmacogenomic Screen of Metformin Action
$586,765Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2017 · DK
Development of double-targeted vectors for long-term vascular expression in vivo
$586,759David T Curiel · University Of Alabama At Birmingham · R01 · FY2009 · HL
Pulmonary and Immunologic Effects of Marijuana Use on HIV and Viral Immunity
$586,689Michael D Roth · University Of California Los Angeles · R01 · FY2010 · DA